MAPKAPK2 and atherosclerosis: Interestingly, a different CaMKII-MK2‒driven downstream pathway in atherosclerotic lesional macrophages promotes advanced atherosclerosis progression by impairing clearance of apoptotic cells (efferocytosis) and suppressing resolution of inflammation [11, 12].